GEODE CAPITAL MANAGEMENT, LLC
Position in IOVA — Iovance Biotherapeutics, Inc.
CIK 1214717
BOSTON, MA
Position in IOVA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$30,089,818
+$8,272,642 QoQ
Shares Held
8,572,598
+7.3% QoQ
Ownership
1.92%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in IOVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GEODE CAPITAL MANAGEMENT, LLC holds $18,583,356,554 across 528 Biotechnology names. IOVA ranks #95 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,139,621 | $2,741,586,360 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,607,732 | $2,014,838,051 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,660,385 | $880,241,584 | |
| 4 | INSM |
INSMED Inc
|
4,450,389 | $727,727,608 | |
| 5 | MRNA |
Moderna, Inc.
|
9,435,132 | $479,304,705 | |
| 6 | INCY |
Incyte Corp
|
4,703,184 | $442,663,677 | |
| 7 | RPRX |
Royalty Pharma plc
|
7,869,632 | $377,506,246 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
4,918,030 | $365,212,906 |
All Filings in IOVA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $30,089,818 | 8,572,598 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $21,817,176 | 7,991,640 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $14,904,216 | 6,868,303 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $10,645,179 | 6,189,058 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $19,874,431 | 5,968,298 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $43,448,508 | 5,871,420 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $53,044,062 | 5,648,995 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $46,407,986 | 5,786,532 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $81,608,063 | 5,506,617 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $40,951,606 | 5,037,098 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $21,609,820 | 4,749,411 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $29,134,068 | 4,138,362 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $18,570,935 | 3,039,433 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $17,932,774 | 2,806,381 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $25,599,273 | 2,672,158 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $29,144,374 | 2,639,889 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $31,604,813 | 1,898,187 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $35,274,711 | 1,847,811 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $44,043,055 | 1,786,012 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $47,596,720 | 1,829,236 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $54,544,576 | 1,722,823 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $77,017,550 | 1,659,861 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $51,519,306 | 1,564,985 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $43,951,457 | 1,601,146 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $53,064,727 | 1,772,369 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||